AHCONasdaqServices-Home Health Care ServicesFiscal year ends December 31
AdaptHealth Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$5.88−0.14 (-2.33%)
Close on Oct 19, 2026
- Market cap
- $800.39M
- P/E (TTM)
- –
- Dividend yield
- –
AdaptHealth Corp. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Sleep Health | $1.38B | $1.35B | $1.29B | $1.10B | – | – | – | 42.5% | +2.1% |
| Respiratory Health | $691.16M | $651.15M | $614.56M | $554.14M | – | – | – | 21.3% | +6.1% |
| Diabetes Health | $592.41M | $614.41M | $660.04M | $687.09M | – | – | – | 18.3% | -3.6% |
| Wellness at Home | $583.14M | $646.20M | $633.86M | $625.59M | – | – | – | 18.0% | -9.8% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| HME | – | – | $206.53M | $220.80M | $209.74M | $113.88M | $85.46M | – | – |
| Respiratory | – | – | $598.82M | $555.04M | $458.29M | $152.47M | $87.20M | – | – |
| Sleep | – | – | $1.24B | $1.07B | $891.38M | $411.22M | $305.39M | – | – |
| Other | – | – | $301.15M | $261.62M | $186.09M | $71.25M | $43.84M | – | – |
| Supplies to the home | – | – | $192.48M | $179.33M | $167.83M | $145.62M | $7.76M | – | – |
| Diabetes | – | – | $660.04M | $687.09M | $541.21M | $161.96M | – | – | – |
By region
From the segment and revenue-disaggregation notes of AdaptHealth's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.